Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF

Grade Last Price % Change Price Change
D 29.37 -4.21% -1.29
CNCR closed down 4.21 percent on Thursday, March 4, 2021, on 1.32 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical CNCR trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
200 DMA Support Bullish 0.00%
Multiple of Ten Bearish Other 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish -4.21%
Stochastic Reached Oversold Weakness -4.21%
Gapped Down Weakness -4.21%
Older End-of-Day Signals for CNCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Support about 18 hours ago
Down 5% about 18 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Gap Down Partially Closed about 22 hours ago
Gapped Down (Full) about 22 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Loncar Cancer Immunotherapy ETF Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.


Classification

Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Cancer SPDR Betashares Immune System Immunotherapy Cancer Immunotherapy Technology Sector Technology Sectors Lonca Biotechnology Sectors Loncar Cancer Immunotherapy Index

Top 10 Components

Symbol Grade Price % Change Allocation
IMAB B 0.00 5.51
BGNE C 0.00 4.84
NKTR B 0.00 4.66
ALLO C 0.00 4.36
RCUS D 0.00 4.10
ARGX C 0.00 4.02
XNCR D 0.00 3.96
SRRK D 0.00 3.90
MGNX C 0.00 3.80
BMY F 0.00 3.51
View All CNCR Holdings

Is CNCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.818
52 Week Low 12.0
Average Volume 9,759
200-Day Moving Average 29.16
50-Day Moving Average 33.31
20-Day Moving Average 33.07
10-Day Moving Average 31.62
Average True Range 0.92
ADX 26.84
+DI 17.05
-DI 45.62
Chandelier Exit (Long, 3 ATRs ) 33.07
Chandelier Exit (Short, 3 ATRs ) 31.80
Upper Bollinger Band 36.50
Lower Bollinger Band 29.65
Percent B (%b) -0.04
BandWidth 20.71
MACD Line -0.84
MACD Signal Line -0.46
MACD Histogram -0.3789
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.60
Resistance 3 (R3) 31.74 31.14 31.23
Resistance 2 (R2) 31.14 30.57 31.07 31.11
Resistance 1 (R1) 30.26 30.22 29.96 30.11 30.98
Pivot Point 29.65 29.65 29.50 29.58 29.65
Support 1 (S1) 28.77 29.09 28.47 28.63 27.76
Support 2 (S2) 28.17 28.73 28.10 27.63
Support 3 (S3) 27.28 28.17 27.51
Support 4 (S4) 27.14